GammaMabs Pharma


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

GammaMabs Pharma is a biotechnology company developing a new monoclonal antibody targeting gynecological cancers, including ovarian cancer. Ovarian cancer is responsible for over 50 000 deaths every year in Europe and the United States. It has a poor prognosis as it is often diagnosed at an advanced stage due to a lack of systematic screening. Increasing resistance to traditional chemotherapy treatments justifies research into targeted therapeutic solutions, such as monoclonal antibodies.

GammaMabs Pharma is a biotechnology company developing a new monoclonal antibody targeting gynecological cancers, including ovarian cancer. Ovarian cancer is responsible for over 50 000 deaths every year in Europe and the United States. It has a poor...Show all

Company (Alive / Active)

Phone:

Fax:




France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
GammaMabs Pharma $0M Sep 30, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related GammaMabs Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)